
USFDA APPLICATION NUMBER - 215033 / DOSAGE - SOLUTION;INTRAVENOUS - 100MG/4ML (25MG/ML)
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| BENDAMUSTINE HYDROCHLORIDE(UNII: 981Y8SX18M) (Bendamustine - UNII:9266D9P3PQ) | BENDAMUSTINE HYDROCHLORIDE | 25mg in 1 |
Inactive Ingredients
| Ingredient Name | Apotex Corp | Eagle Pharmaceuticals, Inc | Teva Pharmaceuticals USA, Inc. |
|---|---|---|---|
| ALCOHOL(3K9958V90M) | |||
| MONOTHIOGLYCEROL(AAO1P0WSXJ) | |||
| POLYETHYLENE GLYCOL 400(B697894SGQ) | |||
| POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | |||
| PROPYLENE GLYCOL(6DC9Q167V3) | |||
| SODIUM HYDROXIDE (55X04QC32I) | |||
| SODIUM HYDROXIDE(55X04QC32I) |